In this video, health care analysts David Williamson and Max Macaluso discuss Dendreon's upcoming third-quarter earnings. David highlights what investors need to look for in the company's press release -- and more importantly, the conference call. Watch and be prepared for Friday's big news.

David Williamson owns shares of Johnson & Johnson. The Motley Fool owns shares of Dendreon and Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.